New patent for Boehringer Ingelheim drug JENTADUETO XRBy DrugPatentWatch – Make Better Decisions / March 27, 2024 Annual Drug Patent Expirations for JENTADUETO+XR Jentadueto Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are eight…Source